NCT02663440 2016-01-26Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma MultiformeZhejiang Cancer HospitalPhase 2 Unknown41 enrolled